• Ionis spinout Akcea files for approval of volanesorsen fiercebiotech
    September 05, 2017
    Akcea Therapeutics has filed for FDA approval of volanesorsen. The Ionis Pharmaceuticals spinout sees the filing positioning it to bring the treatment of familial chylomicronemia syndrome (FCS) to market in the U.S. next year.
PharmaSources Customer Service